Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
eREX, Apr-Dec (Cumulative 3Q) Net Income Decreases by 15%, Exceeds Full-Year Plan
9517 eREX Co.,Ltd. 【IFRS】
Earnings ReporteREX Co.,Ltd. <9517> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 10th (15:30). The consolidated net income for the cumulative third quarter of the fiscal year ending March 2026 (April to December) decreased 15.4% from the same period last year to 3.73 billion yen. Progress toward the full-year plan of 3.41 billion yen is 109.4%, but it was lower than the same period of the previous year of 208.5%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the January to March period (4Q) is expected to further decrease loss of 0.32 billion yen (compared to a loss of 2.29 billion yen in the same period last year).
In the most recent three-month period, from October to December (3Q), the consolidated net income decreased to 2.14 billion yen, a 21.3% decrease compared to the same period last year. The operating profit margin drastically worsened from 6.6% in the same period last year to 2.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 184,305 | -14,205 | -13,175 | -15,204 | -256.4 | ー | Feb 9, 2024 | IFRS |
| Apr - Dec, 2024 | 126,583 | 8,008 | 8,322 | 4,416 | 60.8 | 131.5 | Feb 12, 2025 | IFRS |
| Apr - Dec, 2025 | 127,979 | 4,655 | 5,567 | 3,736 | 47.9 | 74.1 | Feb 10, 2026 | IFRS |
| YoY | +1.1% | -41.9% | -33.1% | -15.4% | -21.2% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 88,003 | 1,993 | 1,979 | 431 | 5.8 | 11 | May 12, 2025 | IFRS |
| Oct - Mar, 2025 Guidance | 89,637 | 4,980 | 4,298 | 1,828 | 23.4 | 11 | Nov 11, 2025 | IFRS |
| YoY | +1.9% | +149.9% | +117.2% | +324.1% | +301.9% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 244,977 | -21,949 | -19,949 | -21,347 | -359.9 | 0 | May 10, 2024 | IFRS |
| Mar, 2025 | 171,217 | 7,137 | 6,330 | 2,118 | 28.7 | 11 | May 12, 2025 | IFRS |
| Mar, 2026 Guidance | 176,181 | 8,601 | 7,510 | 3,415 | 43.8 | 11 | May 12, 2025 | IFRS |
| YoY | +2.9% | +20.5% | +18.6% | +61.2% | +52.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 43,369 | 2,864 | 3,971 | 2,729 | 37.6 | 6.6 | Feb 12, 2025 | IFRS |
| Jan - Mar, 2025 | 44,634 | -871 | -1,992 | -2,298 | -31.1 | -2.0 | May 12, 2025 | IFRS |
| Apr - Jun, 2025 | 37,047 | 1,453 | 535 | -135 | -1.7 | 3.9 | Aug 8, 2025 | IFRS |
| Jul - Sep, 2025 | 49,497 | 2,168 | 2,677 | 1,722 | 22.1 | 4.4 | Nov 11, 2025 | IFRS |
| Oct - Dec, 2025 | 41,435 | 1,034 | 2,355 | 2,149 | 27.6 | 2.5 | Feb 10, 2026 | IFRS |
| YoY | -4.5% | -63.9% | -40.7% | -21.3% | -26.7% |
Related Articles
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow
OHASHI TECHNICA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 22%, Oct-Dec Ordinary Profit Increases by 29%
KAPPA CREATE, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 38%, Oct-Dec Ordinary Profit Turns to Loss
Carlit, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 30%, Oct-Dec Ordinary Profit Increases by 47%
KYOKUTO KAIHATSU, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 48%, Oct-Dec Ordinary Profit Increases by 66%
iRidge, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 34%
APPLE INTERNATIONAL, Ordinary Profit Forecast for Last Fiscal Year Revised Downward by 20%
AIGAN, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Loss Narrows
ULVAC, First Half Ordinary Profit Decreases by 43%, Oct-Dec Ordinary Profit Decreases by 27%
Ledax, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Loss Widens